JAMES ADAMS: Open Payments
NPI 1184681439 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 23 payments from 7 companies in 2025. Trend: 2023 $994 · 2024 $1,368 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 7 | $557 |
| Gilead Sciences, Inc. | 8 | $470 |
| Merck Sharp & Dohme LLC | 4 | $167 |
| ABBVIE INC. | 1 | $123 |
| THD America, Inc. | 1 | $113 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Novo Nordisk Inc | 1 | $27 |
Products named: CABENUVA, MAVYRET, APRETUDE, PIFELTRO, SHINGRIX, Yeztugo.
Industry payments across CA — which companies pay providers there.
